{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:19:43Z","timestamp":1791976783842,"version":"4.4.0"},"reference-count":157,"publisher":"Portland Press Ltd.","issue":"7","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Ageing is a major risk factor for the development of cardiovascular disease (CVD) and cancer. Whilst the cumulative effect of exposure to conventional cardiovascular risk factors is important, recent evidence highlights clonal haematopoiesis of indeterminant potential (CHIP) as a further key risk factor. CHIP reflects the accumulation of somatic, potentially pro-leukaemic gene mutations within haematopoietic stem cells over time. The most common mutations associated with CHIP and CVD occur in genes that also play central roles in the regulation of inflammation. While CHIP carriers have a low risk of haematological malignant transformation (&amp;lt;1% per year), their relative risk of mortality is increased by 40% and this reflects an excess of cardiovascular events. Evidence linking CHIP, inflammation and atherosclerotic disease has recently become better defined. However, there is a paucity of information about the role of CHIP in the development and progression of heart failure, particularly heart failure with preserved ejection fraction (HFpEF). While systemic inflammation plays a role in the pathophysiology of both heart failure with reduced and preserved ejection fraction (EF), it may be of greater relevance in the pathophysiology of HFpEF, which is also strongly associated with ageing. This review describes CHIP and its pathogenetic links with ageing, inflammation and CVD, while providing insight into its putative role in HFpEF.<\/jats:p>","DOI":"10.1042\/cs20200306","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T08:53:51Z","timestamp":1618649631000},"page":"991-1007","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure"],"prefix":"10.1042","volume":"135","author":[{"given":"Leanne","family":"Mooney","sequence":"first","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl S.","family":"Goodyear","sequence":"additional","affiliation":[{"name":"Institute of Immunity, Infection and Inflammation, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Chandra","sequence":"additional","affiliation":[{"name":"The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-8670","authenticated-orcid":false,"given":"Kristina","family":"Kirschner","sequence":"additional","affiliation":[{"name":"Paul O\u2019Gorman Leukaemia Research Centre, Institute for Cancer Science, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhairi","family":"Copland","sequence":"additional","affiliation":[{"name":"Paul O\u2019Gorman Leukaemia Research Centre, Institute for Cancer Science, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Petrie","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninian N.","family":"Lang","sequence":"additional","affiliation":[{"name":"BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"2021113011205140300_B1","first-page":"1","article-title":"Health Survey for Engand: Cardiovascualar Diseases","author":"Department of Health","year":"2017"},{"key":"2021113011205140300_B2","first-page":"1","article-title":"Cancer incidence by age","author":"Cancer Research U.K.","year":"2015-2017"},{"key":"2021113011205140300_B3","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Rep."},{"key":"2021113011205140300_B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","article-title":"Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis","volume":"141","author":"Bick","year":"2020","journal-title":"Circulation"},{"key":"2021113011205140300_B7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol."},{"key":"2021113011205140300_B8","first-page":"1","article-title":"Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation","volume":"41","author":"Mas-Peiro","year":"2019","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B9","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B10","doi-asserted-by":"publisher","first-page":", 400","DOI":"10.1200\/EDBK_239083","article-title":"CHIP, CCUS, and other acronyms: definition, implications, and impact on practice","volume":"39","author":"DeZern","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. B."},{"key":"2021113011205140300_B11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jacc.2019.06.007","article-title":"Clonal hematopoiesis: crossroads of aging, cardiovascular disease, and cancer: JACC Review Topic of the Week","volume":"74","author":"Libby","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/stem.2845","article-title":"Age-related clonal hematopoiesis: stem cells tempting the devil","volume":"36","author":"Busque","year":"2018","journal-title":"Stem Cells"},{"key":"2021113011205140300_B13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"key":"2021113011205140300_B14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S2352-3026(19)30211-X","article-title":"Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states","volume":"7","author":"Gondek","year":"2020","journal-title":"Lancet Haematol."},{"key":"2021113011205140300_B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms12484","article-title":"Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults","volume":"7","author":"Young","year":"2016","journal-title":"Nat. Commun."},{"key":"2021113011205140300_B16","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/s41591-019-0652-7","article-title":"High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants","volume":"25","author":"Razavi","year":"2019","journal-title":"Nat. Med."},{"key":"2021113011205140300_B17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOH.0000000000000509","article-title":"P53 involvement in clonal hematopoiesis of indeterminate potential","volume":"26","author":"Chen","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"2021113011205140300_B18","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging longevity","volume":"153","author":"L\u00f3pez-ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"2021113011205140300_B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.MCHD-0031-2016","article-title":"Myeloid cell origins, differentiation, and clinical implications","volume":"4","author":"Weiskopf","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"2021113011205140300_B20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature05862","article-title":"Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age","volume":"447","author":"Rossi","year":"2007","journal-title":"Nature"},{"key":"2021113011205140300_B21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature21388","article-title":"Autophagy maintains the metabolism and function of young and old (hematopoietic) stem cells","volume":"543","author":"Ho","year":"2017","journal-title":"Nature"},{"key":"2021113011205140300_B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2016.00502","article-title":"Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment","volume":"7","author":"Kovtonyuk","year":"2016","journal-title":"Front. Immunol."},{"key":"2021113011205140300_B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.exphem.2017.11.002","article-title":"An inflammatory environment containing TNF\u03b1 favors Tet2-mutant clonal hematopoiesis","volume":"59","author":"Abegunde","year":"2018","journal-title":"Exp. Hematol."},{"key":"2021113011205140300_B24","doi-asserted-by":"publisher","first-page":"833.e5","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell Stem Cell"},{"key":"2021113011205140300_B25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.seminhematol.2016.11.001","article-title":"Accumulation of DNA damage in the aged hematopoietic stem cell compartment","volume":"54","author":"Beerman","year":"2017","journal-title":"Semin. Hematol."},{"key":"2021113011205140300_B26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.stem.2017.07.010","article-title":"Therapy-related clonal hematopoiesis in patients with non- hematologic cancers is common and impacts clinical outcome","volume":"21","author":"Coombs","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2021113011205140300_B27","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1182\/blood.2019000991","article-title":"Clonal hematopoiesis and risk for hematologic malignancy","volume":"136","author":"Warren","year":"2020","journal-title":"Blood"},{"key":"2021113011205140300_B28","doi-asserted-by":"crossref","DOI":"10.1161\/circ.142.suppl_3.16686","article-title":"Abstract 16686\u202f: Improved diet quality is associated with lower prevalence of clonal hematopoiesis of indeterminate potential","volume":"142","author":"Bhattacharya","year":"2020","journal-title":"Circulation"},{"key":"2021113011205140300_B29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1182\/blood.2019001793","article-title":"Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality","volume":"135","author":"Hansen","year":"2020","journal-title":"Blood"},{"key":"2021113011205140300_B30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood.2019001807","article-title":"Concordance for clonal hematopoiesis is limited in elderly twins","volume":"135","author":"Fabre","year":"2020","journal-title":"Blood"},{"key":"2021113011205140300_B31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1182\/asheducation-2018.1.264","article-title":"Clinical consequences of clonal hematopoiesis of indeterminate potential","volume":"2018","author":"Steensma","year":"2018","journal-title":"Hematology"},{"key":"2021113011205140300_B32","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1200\/JCO.2016.71.6712","article-title":"Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma","volume":"35","author":"Gibson","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"2021113011205140300_B33","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","article-title":"Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis","volume":"3","author":"Cook","year":"2019","journal-title":"Blood Adv."},{"key":"2021113011205140300_B34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","article-title":"Inherited causes of clonal haematopoiesis in 97,691 whole genomes","volume":"586","author":"Bick","year":"2020","journal-title":"Nature"},{"key":"2021113011205140300_B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21217902","article-title":"Clonal hematopoiesis, cardiovascular diseases and hematopoietic stem cells","volume":"21","author":"Kandarakov","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"2021113011205140300_B36","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ng.2413","article-title":"Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis","volume":"44","author":"Busque","year":"2012","journal-title":"Nat. Genet."},{"key":"2021113011205140300_B37","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science (80-)"},{"key":"2021113011205140300_B38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"Tet2 loss leads to increased hematopoietic stem cell self- renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"key":"2021113011205140300_B39","doi-asserted-by":"publisher","first-page":"56.e13","DOI":"10.1016\/j.exphem.2017.08.001","article-title":"Tet2 restrains inflammatory gene expression in macrophages","volume":"55","author":"Cull","year":"2017","journal-title":"Exp. Hematol."},{"key":"2021113011205140300_B40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","article-title":"Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"2021113011205140300_B41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"2021113011205140300_B42","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1074\/jbc.RA118.006795","article-title":"Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners","volume":"294","author":"Sandoval","year":"2019","journal-title":"J. Biol. Chem."},{"key":"2021113011205140300_B43","doi-asserted-by":"publisher","first-page":"E1490","DOI":"10.1073\/pnas.1616420114","article-title":"Dnmt3a restrains mast cell inflammatory responses","volume":"114","author":"Leoni","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011205140300_B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep43592","article-title":"Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patients","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"2021113011205140300_B45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/annrheumdis-2012-202576","article-title":"Janus kinase inhibitors in autoimmune diseases","volume":"72","author":"O\u2019Shea","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"2021113011205140300_B46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"2021113011205140300_B47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/bjh.12099","article-title":"Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population","volume":"160","author":"Nielsen","year":"2013","journal-title":"Br. J. Haematol."},{"key":"2021113011205140300_B48","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3324\/haematol.2010.033191","article-title":"The JAK2 V617F somatic mutation, mortality and cancer risk in the general population","volume":"96","author":"Nielsen","year":"2011","journal-title":"Haematologica"},{"key":"2021113011205140300_B49","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/sj.leu.2404292","article-title":"The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors","volume":"20","author":"Sidon","year":"2006","journal-title":"Leukemia"},{"key":"2021113011205140300_B50","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1200\/JCO.2010.33.4938","article-title":"Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes","volume":"29","author":"Thol","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"2021113011205140300_B51","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1200\/jco.2012.47.3314","article-title":"Prognostic score including gene mutations in chronic myelomonocytic leukemia","volume":"31","author":"Itzykson","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"2021113011205140300_B52","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ajh.23596","article-title":"IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution","volume":"89","author":"Lin","year":"2014","journal-title":"Am. J. Hematol."},{"key":"2021113011205140300_B54","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3324\/haematol.2014.114157","article-title":"ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian acute myeloid leukemia study group","volume":"100","author":"Paschka","year":"2015","journal-title":"Haematologica"},{"key":"2021113011205140300_B55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ajh.23734","article-title":"SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution","volume":"89","author":"Lin","year":"2014","journal-title":"Am. J. Hematol."},{"key":"2021113011205140300_B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms8307","article-title":"Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex","volume":"6","author":"Balasubramani","year":"2015","journal-title":"Nat. Commun."},{"key":"2021113011205140300_B57","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","article-title":"ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression","volume":"22","author":"Abdel-Wahab","year":"2012","journal-title":"Cancer Cell"},{"key":"2021113011205140300_B58","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2017-06-789669","article-title":"Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies","volume":"131","author":"Yang","year":"2018","journal-title":"Blood"},{"key":"2021113011205140300_B59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/medicina45020018","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"45","author":"Rinkuniene","year":"2009","journal-title":"Medicina"},{"key":"2021113011205140300_B60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11745-014-3977-5","article-title":"Oxidized low-density lipoprotein inhibits THP-1-derived macrophage autophagy via TET2 down-regulation","volume":"50","author":"Li","year":"2015","journal-title":"Lipids"},{"key":"2021113011205140300_B61","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.113.002887","article-title":"TET2 is a master regulator of smooth muscle cell plasticity","volume":"128","author":"Liu","year":"2013","journal-title":"Circulation"},{"key":"2021113011205140300_B62","doi-asserted-by":"publisher","first-page":"76423","DOI":"10.18632\/oncotarget.13121","article-title":"Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-\/- mice","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"key":"2021113011205140300_B63","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1007\/s10439-015-1491-4","article-title":"Low shear stress inhibited endothelial cell autophagy through TET2 downregulation","volume":"44","author":"Yang","year":"2016","journal-title":"Ann. Biomed. Eng."},{"key":"2021113011205140300_B64","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science (80-)"},{"key":"2021113011205140300_B65","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jacc.2010.06.029","article-title":"Coronary calcium score improves classification of coronary heart disease risk in the elderly: The Rotterdam study","volume":"56","author":"Elias-Smale","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B66","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in &gt;300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"2021113011205140300_B67","doi-asserted-by":"publisher","DOI":"10.1161\/circ.142.suppl_3.17182","article-title":"Abstract 17182\u202f: Coronary endothelial dysfunction in humans is associated with elevated expression of clonal hematopoiesis of indeterminate potential","volume":"142","author":"Ganji","journal-title":"Circulation"},{"key":"2021113011205140300_B68","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"335","author":"Fuster","year":"2017","journal-title":"Science (80-)"},{"key":"2021113011205140300_B69","doi-asserted-by":"crossref","first-page":"Abstract 15355","DOI":"10.1161\/circ.142.suppl_3.15355","article-title":"Interleukin-1beta inhibition attenuates accelerated atherosclerosis in mice with Tet2 loss of function in a sex-dependent fashion","volume":"142","author":"Vromman","year":"2020)","journal-title":"Circulation"},{"key":"2021113011205140300_B70","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ. Res."},{"key":"2021113011205140300_B71","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.309799","article-title":"Extensive proliferation of a subset of differentiated, yet plastic, medial vascular smooth muscle cells contributes to neointimal formation in mouse injury and atherosclerosis models","volume":"119","author":"Chappell","year":"2016","journal-title":"Circ. Res."},{"key":"2021113011205140300_B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.95890","article-title":"Diverse cellular architecture of atherosclerotic plaque derives from clonal expansion of a few medial SMCs","volume":"2","author":"Jacobsen","year":"2017","journal-title":"JCI Insight"},{"key":"2021113011205140300_B73","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.113.002887","article-title":"Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity","volume":"128","author":"Liu","year":"2013","journal-title":"Circulation"},{"key":"2021113011205140300_B74","doi-asserted-by":"publisher","first-page":"36112","DOI":"10.1074\/jbc.M703914200","article-title":"Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1\/phosphatidylinositol 3-kinase\/Akt2 feedback signaling","volume":"282","author":"Martin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021113011205140300_B75","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCRESAHA.118.313283","article-title":"Macrophage inflammation, erythrophagocytosis and accelerated atherosclerosis in Jak2V617F mice","volume":"123","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"key":"2021113011205140300_B76","doi-asserted-by":"crossref","first-page":"Abstract 15575","DOI":"10.1161\/circ.142.suppl_3.15575","article-title":"The clonal hematopoiesis mutation Jak2 V617F aggravates NETosis and endothelial injury in mouse arteries with erosion-like intimas","volume":"142","author":"Molinaro","year":"2020","journal-title":"Circulation"},{"key":"2021113011205140300_B77","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B78","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B79","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ijcard.2018.04.001","article-title":"Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction","volume":"271","author":"Streng","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"2021113011205140300_B80","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","article-title":"Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction","volume":"72","author":"Tromp","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B81","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ. Res."},{"key":"2021113011205140300_B82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/eurheartj\/ehaa845","article-title":"Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A-and TET2-driver genemutations","volume":"42","author":"Assmus","year":"2021","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B83","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.3626","article-title":"DNMT3A clonal hematopoiesis-driver mutations are associated with profound changes in monocyte and T cell signatures in humans with heart failure","author":"Abplanalp","year":"2020","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B84","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"2021113011205140300_B85","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial structure and function differ in systolic and diastolic heart failure","volume":"113","author":"Van Heerebeek","year":"2006","journal-title":"Circulation"},{"key":"2021113011205140300_B86","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/j.cardfail.2019.07.150","article-title":"Tissue is the issue: endomyocardial biopsy characterization of heart failure with preserved ejection fraction and incident cardiac amyloidosis","volume":"25","author":"Hahn","year":"2019","journal-title":"J. Card. Fail."},{"key":"2021113011205140300_B87","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/01.CIR.0000155257.33485.6D","article-title":"Cardiomyocyte stiffness in diastolic heart failure","volume":"111","author":"Borb\u00e9ly","year":"2005","journal-title":"Circulation"},{"key":"2021113011205140300_B88","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"Van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"2021113011205140300_B89","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","article-title":"Diastolic tissue doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction","volume":"57","author":"Kasner","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B90","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/CIRCULATIONAHA.109.850677","article-title":"Passive stiffness of myocardium from congenital heart disease and implications for diastole","volume":"121","author":"Chaturvedi","year":"2010","journal-title":"Circulation"},{"key":"2021113011205140300_B91","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"2021113011205140300_B92","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"2021113011205140300_B93","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.cardfail.2009.03.006","article-title":"Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction","volume":"15","author":"Desai","year":"2009","journal-title":"J. Card. Fail."},{"key":"2021113011205140300_B94","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/eurjhf\/hft106","article-title":"Biomarkers of heart failure with normal ejection fraction: a systematic review","volume":"15","author":"Cheng","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"2021113011205140300_B95","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/ejhf.430","article-title":"Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use","volume":"17","author":"D'Elia","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"2021113011205140300_B96","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/ejhf.414","article-title":"Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction","volume":"17","author":"Sanders-Van Wijk","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"2021113011205140300_B97","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/eurjhf\/hfs130","article-title":"Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction","volume":"14","author":"Santhanakrishnan","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"2021113011205140300_B98","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","article-title":"Heart failure with preserved ejection fraction: From mechanisms to therapies","volume":"39","author":"Lam","year":"2018","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cardfail.2005.08.003","article-title":"High-sensitivity C-reactive protein and parameters of left ventricular dysfunction","volume":"12","author":"Shah","year":"2006","journal-title":"J. Card. Fail."},{"key":"2021113011205140300_B100","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.amjhyper.2007.01.023","article-title":"Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome","volume":"20","author":"Sciarretta","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"2021113011205140300_B101","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B102","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: The Health, Aging, and Body Composition Study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"JAMA Cardiol."},{"key":"2021113011205140300_B103","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","article-title":"Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1\u03b2\/NLRP3 inflammasome","volume":"71","author":"Sano","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-42209-7","article-title":"Distinct phenotypes induced by three degrees of transverse aortic constriction in mice","volume":"9","author":"Richards","year":"2019","journal-title":"Sci. Rep."},{"key":"2021113011205140300_B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.115.002724","article-title":"Heart failure with preserved ejection fraction induces beiging in adipose tissue","volume":"9","author":"Valero-Mun\u00f5z","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"2021113011205140300_B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep34036","article-title":"Histone deacetylase inhibitor phenylbutyrate exaggerates heart failure in pressure overloaded mice independently of HDAC inhibition","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"2021113011205140300_B107","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","article-title":"CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease","volume":"123","author":"Sano","year":"2018","journal-title":"Circ. Res."},{"key":"2021113011205140300_B108","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044444","article-title":"An important role for DNMT3A-mediated DNA methylation in cardiomyocyte metabolism and contractility","author":"Madsen","year":"2020","journal-title":"Circulation"},{"key":"2021113011205140300_B109","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jacbts.2019.05.013","article-title":"JAK2V617F-mediated clonal hematopoiesis accelerates pathological remodeling in murine heart failure","volume":"4","author":"Sano","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"2021113011205140300_B110","doi-asserted-by":"publisher","first-page":"Abstract 12873","DOI":"10.1161\/circ.142.suppl_3.12873","article-title":"Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension through ALK1","volume":"142","author":"Kimishima","year":"2020","journal-title":"Circulation"},{"key":"2021113011205140300_B111","doi-asserted-by":"publisher","first-page":"e135204","DOI":"10.1172\/jci.insight.135204","article-title":"Tet2-mediated clonal hematopoiesis in non-conditioned mice accelerates age-associated cardiac dysfunction","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"key":"2021113011205140300_B112","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","article-title":"Epidemiology of heart failure with preserved ejection fraction","volume":"14","author":"Dunlay","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"2021113011205140300_B113","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"2021113011205140300_B114","doi-asserted-by":"publisher","first-page":"631","DOI":"10.7326\/0003-4819-137-8-200210150-00006","article-title":"Outcome of congestive heart failure in elderly persons\u202f: influence of left ventricular systolic function\u202f: The Cardiovascular Health Study","volume":"137","author":"Gottdiener","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"2021113011205140300_B115","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0002-9149(00)01165-6","article-title":"Congestive heart failure despite normal left ventricular systolic function in a population-based sample: The Strong Heart Study","volume":"86","author":"Devereux","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"2021113011205140300_B116","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure. A Report From the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B117","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: A report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B118","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: A report from the Acute Decompensated Heart Failure National Registry (ADHERE) database","volume":"47","author":"Yancy","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B120","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted county, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"2021113011205140300_B121","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jacc.2003.11.040","article-title":"Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York heart failure registry","volume":"43","author":"Klapholz","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B122","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/bmj.327.7406.78","article-title":"Prognosis in heart failure with preserved left ventricular systolic function: prospective cohort study","volume":"327","author":"MacCarthy","year":"2003","journal-title":"Br. Med. J."},{"key":"2021113011205140300_B123","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jacc.2009.02.046","article-title":"Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction. Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)","volume":"53","author":"van Veldhuisen","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011205140300_B124","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B125","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/hrt.2007.117978","article-title":"The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction","volume":"94","author":"Yip","year":"2008","journal-title":"Heart"},{"key":"2021113011205140300_B126","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B127","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: The Ancillary Digitalis Investigation Group Trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"2021113011205140300_B128","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ejheart.2004.02.003","article-title":"Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC)","volume":"6","author":"Bergstr\u00f6m","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"2021113011205140300_B129","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"2021113011205140300_B130","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCHEARTFAILURE.112.972794","article-title":"Baseline characteristics of patients in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial","volume":"6","author":"Shah","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"2021113011205140300_B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCHEARTFAILURE.118.004962","article-title":"Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial","volume":"11","author":"Solomon","year":"2018","journal-title":"Circ. Heart Fail."},{"key":"2021113011205140300_B132","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1001\/jamainternmed.2015.0924","article-title":"A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010","volume":"175","author":"Gerber","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"2021113011205140300_B133","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.108.815944","article-title":"Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute","volume":"119","author":"Lee","year":"2009","journal-title":"Circulation"},{"key":"2021113011205140300_B134","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B135","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0002-9343(00)00601-X","article-title":"Systolic versus diastolic heart failure in community practice: Clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors","volume":"109","author":"Philbin","year":"2000","journal-title":"Am. J. Med."},{"key":"2021113011205140300_B136","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B137","doi-asserted-by":"publisher","first-page":"s22","DOI":"10.7861\/clinmedicine.14-6-s22","article-title":"Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction","volume":"14","author":"Gurwitz","year":"2014","journal-title":"Clin. Med."},{"key":"2021113011205140300_B138","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0195-668X(02)00845-X","article-title":"Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function","volume":"24","author":"Gustafsson","year":"2003","journal-title":"Eur. Heart J."},{"key":"2021113011205140300_B139","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ejhf.600","article-title":"Reframing the association and significance of co-morbidities in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"2021113011205140300_B140","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.amjmed.2014.08.024","article-title":"Multimorbidity in heart failure: a community perspective","volume":"128","author":"Chamberlain","year":"2015","journal-title":"Am. J. Med."},{"key":"2021113011205140300_B141","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/ng.2700","article-title":"Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications","volume":"45","author":"Bonnefond","year":"2013","journal-title":"Nat. Genet."},{"key":"2021113011205140300_B142","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1161\/CIRCULATIONAHA.118.034720","article-title":"Heart failure with preserved ejection fraction in the young","volume":"138","author":"Tromp","year":"2018","journal-title":"Circulation"},{"key":"2021113011205140300_B143","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/jgs.16050","article-title":"Younger- vs older-old patients with heart failure with preserved ejection fraction","volume":"67","author":"Matsushita","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"2021113011205140300_B144","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ijcard.2015.09.114","article-title":"Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients","volume":"202","author":"Zacharias","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"2021113011205140300_B145","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cub.2019.07.011","article-title":"Age-related clonal haemopoiesis is associated with increased epigenetic age","volume":"29","author":"Robertson","year":"2019","journal-title":"Curr. Biol."},{"key":"2021113011205140300_B146","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/ije\/dyu277","article-title":"The epigenetic clock is correlated with physical and cognitive fitness in the Lothian Birth Cohort 1936","volume":"44","author":"Marioni","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"2021113011205140300_B147","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.18632\/aging.101020","article-title":"DNA methylation-based measures of biological age: meta-analysis predicting time to death","volume":"8","author":"Chen","year":"2016","journal-title":"Aging (Albany N.Y.)"},{"key":"2021113011205140300_B148","doi-asserted-by":"publisher","DOI":"10.1161\/circ.141.suppl_1.11","article-title":"Abstract 11: Prospective association of Tet2 mediated clonal hematoopoiesis and heart failure and its subtypes in postmenopausal women","volume":"141","author":"Eaton","year":"2020","journal-title":"Circulation"},{"key":"2021113011205140300_B149","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.2019.19191","article-title":"Association of premature natural and surgical menopause with incident cardiovascular disease","volume":"322","author":"Honigberg","year":"2019","journal-title":"JAMA"},{"key":"2021113011205140300_B150","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1210\/jc.2008-0701","article-title":"Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study","volume":"94","author":"Lee","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113011205140300_B151","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13668-013-0069-8","article-title":"The influence of energetic factors on biomarkers of postmenopausal breast cancer risk","volume":"3","author":"Neilson","year":"2014","journal-title":"Curr. Nutr. Rep."},{"key":"2021113011205140300_B152","article-title":"Premature Menopause, Clonal Hematopoiesis, and Coronary Artery disease in Post Menopausal Women. Circ 143, 410-423, 10.1161\/CIRCULATIONAHA.120.051775","author":"Honigberg","year":"2021"},{"key":"2021113011205140300_B153","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"2021113011205140300_B154","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"2021113011205140300_B155","first-page":"Abstract 15111","article-title":"TET2-driven clonal hematopoiesis predicts enhanced response to canakinumab in the CANTOS Trial: an exploratory analysis","volume":"138","author":"Svensson","year":"2019","journal-title":"Circ. Genet Genomics"},{"key":"2021113011205140300_B156","doi-asserted-by":"publisher","first-page":"Supplement 1","DOI":"10.2337\/db18-164-OR","article-title":"SGLT2 inhibitors suppress NLRP3 inflammasome activity via changes in ketones and insulin in type 2 diabetes and cardiovascular diseases","volume":"67","author":"Lee","year":"2018","journal-title":"Diabetes"},{"key":"2021113011205140300_B157","doi-asserted-by":"publisher","first-page":"700.e6","DOI":"10.1016\/j.stem.2018.10.004","article-title":"PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy","volume":"23","author":"Hsu","year":"2018","journal-title":"Cell Stem Cell"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/7\/991\/908289\/cs-2020-0306c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/7\/991\/908289\/cs-2020-0306c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:17:51Z","timestamp":1638274671000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/135\/7\/991\/228383\/Clonal-haematopoiesis-of-indeterminate-potential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":157,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,4,16]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20200306","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4]]},"published":{"date-parts":[[2021,4]]}}}